MSP Recovery (NASDAQ:MSPR) vs. Phreesia (NYSE:PHR) Head-To-Head Analysis

MSP Recovery (NASDAQ:MSPR) and Phreesia (NYSE:PHR) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, risk, analyst recommendations, institutional ownership, profitability, valuation and earnings.

Volatility & Risk

MSP Recovery has a beta of -2.9, suggesting that its share price is 390% less volatile than the S&P 500. Comparatively, Phreesia has a beta of 0.67, suggesting that its share price is 33% less volatile than the S&P 500.

Insider & Institutional Ownership

3.8% of MSP Recovery shares are held by institutional investors. Comparatively, 92.1% of Phreesia shares are held by institutional investors. 50.5% of MSP Recovery shares are held by company insiders. Comparatively, 5.5% of Phreesia shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Profitability

This table compares MSP Recovery and Phreesia’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
MSP Recovery	-7,328.48%	-326.80%	-81.27%
Phreesia	-1.16%	-1.31%	-0.94%

Valuation and Earnings

This table compares MSP Recovery and Phreesia”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
MSP Recovery	$9.81 million	0.04	-$360.50 million	($572.83)	0.00
Phreesia	$463.21 million	1.45	-$58.53 million	($0.10)	-111.50

Phreesia has higher revenue and earnings than MSP Recovery. Phreesia is trading at a lower price-to-earnings ratio than MSP Recovery, indicating that it is currently the more affordable of the two stocks.

Analyst Recommendations

This is a breakdown of current recommendations for MSP Recovery and Phreesia, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
MSP Recovery	1	0	0	0	1.00
Phreesia	1	1	17	0	2.84

Phreesia has a consensus target price of $28.65, indicating a potential upside of 156.92%. Given Phreesia’s stronger consensus rating and higher possible upside, analysts plainly believe Phreesia is more favorable than MSP Recovery.

Summary

Phreesia beats MSP Recovery on 12 of the 14 factors compared between the two stocks.

About MSP Recovery

MSP Recovery, Inc. engages in the development of healthcare recoveries and data analytics software. It also focuses on the identification and recoveries of improper payments made by Medicare, Medicaid, and commercial insurance spaces using data and analytics. The company was founded by John H. Ruiz, Frank C. Quesada, and Diana Diaz on July 8, 2014 and is headquartered in Miami, FL.

About Phreesia

Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients. The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a web-based dashboard for healthcare services clients; PhreesiaPads, a self-service intake tablets; and Arrivals Kiosks, an on-site kiosks. It serves patients; single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies. The company was incorporated in 2005 and is based in Wilmington, Delaware.